50KRW
5.85 BKRW
68.64 BKRW
15.11 M
About MEDIPOST
Sector
Industry
CEO
Won-Il Oh
Website
Headquarters
Seongnam
Founded
2000
ISIN
KR7078160009
FIGI
BBG000F8XYW9
Medipost Co., Ltd. engages in the development and manufacture of stem cell biotechnology products. It operates through the following business divisions: Cord Blood Bank, Stem Cell Therapy, Health Functional Food, Import and Distribution of Natural Cosmetics and Healthcare Services. The Cord Blood Bank division is involved in collecting and storing stem cells from the newborn's umbilical cord. The Stem Cell Therapy division manufactures allogeneic stem cell drug products. The Health Functional Food division offers vitamins and nutritional supplements. The Import and Distribution of Natural Cosmetics division is involved in the sales and marketing of natural cosmetics imported by Pevonia Inc. The Healthcare Services division provides healthcare solutions such as bizcare, insu-care, affiliate, telehealth services and medical devices through web, mobile, and call centers. The company was founded by Yoon-Sun Yang and Won-Il Oh on June 26, 2000 and is headquartered in Seongnam, South Korea.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of 078160 is 6890 KRW — it has increased by 2.84% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on KRX exchange MEDIPOST stocks are traded under the ticker 078160.
078160 stock is 6.07% volatile and has beta coefficient of 0.69. Check out the list of the most volatile stocks — is MEDIPOST there?
MEDIPOST revenue for the last quarter amounts to 15.40 B KRW despite the estimated figure of 14.00 B KRW. In the next quarter revenue is expected to reach 15.80 B KRW.
Yes, you can track MEDIPOST financials in yearly and quarterly reports right on TradingView.
078160 stock has fallen by 0.29% compared to the previous week, the month change is a 3.09% fall, over the last year MEDIPOST has showed a 45.58% decrease.
078160 net income for the last quarter is 11.40 B KRW, while the quarter before that showed −2.81 B KRW of net income which accounts for 506.04% change. Track more MEDIPOST financial stats to get the full picture.
Today MEDIPOST has the market capitalization of 228.46 B, it has decreased by 2.42% over the last week.
No, 078160 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, 078160 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade MEDIPOST stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So MEDIPOST technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating MEDIPOST stock shows the sell signal. See more of MEDIPOST technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. MEDIPOST EBITDA is −19.81 B KRW, and current EBITDA margin is −28.95%. See more stats in MEDIPOST financial statements.